We’re innovative thought leaders and determined advocates who partner with visionary organizations to change health care.
We’re innovative thought leaders and determined advocates who partner with visionary organizations to change health care.
We’re innovative thought leaders and determined advocates who partner with visionary organizations to change health care.
In addition to being mission-driven, we contribute 5% of profits to charities that deliver health care to those in need.
In addition to being mission-driven, we contribute 5% of profits to charities that deliver health care to those in need.
In addition to being mission-driven, we contribute 5% of profits to charities that deliver health care to those in need.
We're working to improve health for all, including enhancing quality, reducing costs, and expanding access to care.
We're working to improve health for all, including enhancing quality, reducing costs, and expanding access to care.
We're working to improve health for all, including enhancing quality, reducing costs, and expanding access to care.
Impact Health Policy Partners is the only mission-driven, public interest government relations firm focused on health and well-being.
OUR SERVICES
If you believe that every American deserves to be healthy and well, contact Impact Health Policy Partners to learn how our expertise can help you achieve your goals.
Policy Hub, managed by Impact Health Policy Partners, is the only comprehensive database of Federal health policy developments, cataloged by over 200 healthcare topics and programs. Regulations, reimbursement, grants, ACA implementation, hearing summaries, CRS Reports, pending legislation – you get it all here, with comprehensive, expert analysis.
Agency Finalizes DTC TV and Radio Advertisement Requirements for Prescription Drugs
The Food and Drug Administration (FDA) issued a final rule to amend its regulations regarding direct-to-consumer (DTC) advertisements for prescription drugs presented in television or radio format to ensure that the major statement relating to side effects and contraindications are be presented in a clear, conspicuous, and neutral manner. What is it. The final rule implements a requirement of the… (Slifer, November 27, 2023) #Food and Drug Administration, #Prescription Drugs
Manufacturer Discount Program Final Guidance Released; Make Clarifications Regarding Specified Manufacturer Phase-In, Applicable Discounts, and Conditions for Coverage
The Centers for Medicare and Medicaid Services (CMS) released the Medicare Part D Manufacturer Program final guidance, pursuant to the Inflation Reduction Act, that becomes effective beginning January 1, 2025. CMS also released the Manufacturer Discount Program Manufacturer Agreement, and the Manufacturer Discount Program Third Party Administrator (TPA) Agreement. Additional details from the final guidance follow: What is it. The… (Slifer, November 17, 2023) #Medicare Part D, #Prescription Drugs